What Oncologists Need to Know Today, A Webcast Series – Week 4
September 25th 2020
Randall A. Oyer, MD, shares key highlights from the Association of Community Cancer Centers National Oncology Conference, the future of virtual meetings in light of the coronavirus disease 2019 pandemic, and innovative efforts dedicated to improving cancer care.
The coronavirus disease 2019 pandemic has increased levels of perceived and post-traumatic stress among oncology providers and patients with cancer alike, which suggest a need for psychosocial support resources to promote emotional resilience and reduce the risk of post-traumatic stress in patients on active therapy.
September 23rd 2020
Cancer is independently associated with mortality in patients admitted to the hospital due to coronavirus disease 2019 (COVID-19) infection.
The coronavirus disease 2019 pandemic is highlighting how independent community oncology practices are the best source for patients to receive care close to home, while also presenting several challenges for practices and their patients.
September 22nd 2020
Quoc-Dien Trinh, MD, discusses the challenges of re-establishing standard surgical procedures in patients with prostate cancer following the initial wave of the coronavirus disease 2019 pandemic.
September 13th 2020
As the impact of the coronavirus disease 2019 pandemic lingers into the later part of 2020, consideration is needed regarding the lasting effects on patients with cancer who may have experienced delayed care or diagnosis.
The coronavirus disease 2019 has had a significant impact on cancer care and created widespread challenges for health care systems across the globe.
The wellbeing and job performance of oncology professionals has been significantly impacted by the COVID-19 pandemic, and although the extent of this impact is varied between countries, it has been suggested to be related to the crude mortality rate of the virus.
September 12th 2020
Because it is likely that COVID-19 will be around for a considerable period of time, it is hoped that all involved in the clinical research establishment can view this experience as a process that needs substantial improvement.
September 3rd 2020
Remdesivir has been associated with a lower mortality rate for patients with cancer and the novel coronavirus disease compared with other agents under examination for this population.
